51 Ken Griffin Pfizer Trades
Ken Griffin acquired 12.1M Pfizer shares worth $304M. That's 0.20% of their equity portfolio (90th largest holding). The first Pfizer trade was made in Q2 2013. Since then Ken Griffin bought shares 68 more times and sold shares on 58 occasions. The investor's estimated purchase price is $438M, resulting in a loss of 31%.
Avg closing price
Price range
Increased shares by 36.1% (+1.95M shares)
Q1 2026
Avg closing price
$26.61
Price range
$25.15
-
$28.08
Sold 47.4% shares (-4.88M shares)
Q4 2025
Avg closing price
$25.23
Price range
$24.23
-
$27.37
Sold 30.8% shares (-4.58M shares)
Q3 2025
Avg closing price
$24.69
Price range
$23.29
-
$25.88
Increased shares by 111.3% (+7.83M shares)
Q2 2025
Avg closing price
$23.32
Price range
$21.59
-
$24.84
Sold 52.7% shares (-7.84M shares)
Q1 2025
Avg closing price
$26.17
Price range
$25.01
-
$27.13
Increased shares by 84.5% (+6.81M shares)
Q4 2024
Avg closing price
$27.11
Price range
$24.80
-
$30.19
Sold 60.5% shares (-12.3M shares)
Q3 2024
Avg closing price
$29.15
Price range
$27.70
-
$31.39
Increased shares by 63.0% (+7.89M shares)
Q2 2024
Avg closing price
$27.53
Price range
$25.26
-
$29.60
Increased shares by 7.6% (+879k shares)
Q1 2024
Avg closing price
$27.75
Price range
$25.89
-
$29.73
Increased shares by 408.5% (+9.34M shares)
Q4 2023
Avg closing price
$30.23
Price range
$26.13
-
$33.94
Increased shares by 7.6% (+162k shares)
Q3 2023
Avg closing price
$35.35
Price range
$32.09
-
$37.51
Increased shares by 39.4% (+601k shares)
Q2 2023
Avg closing price
$38.92
Price range
$36.12
-
$41.79
Increased shares by 27.7% (+331k shares)
Q1 2023
Avg closing price
$43.19
Price range
$39.39
-
$51.26
Sold 70.6% shares (-2.86M shares)
Q4 2022
Avg closing price
$47.94
Price range
$41.75
-
$54.48
Increased shares by 335.8% (+3.12M shares)
Q3 2022
Avg closing price
$48.59
Price range
$43.76
-
$53.42
Sold 34.9% shares (-499k shares)
Q2 2022
Avg closing price
$50.96
Price range
$46.53
-
$55.17
Increased shares by 45.5% (+447k shares)
Q1 2022
Avg closing price
$51.89
Price range
$45.75
-
$56.69
Sold 81.5% shares (-4.34M shares)
Q4 2021
Avg closing price
$49.55
Price range
$41.32
-
$61.25
Increased shares by 649.6% (+4.61M shares)
Q3 2021
Avg closing price
$44.30
Price range
$39.25
-
$50.42
Sold 91.3% shares (-7.45M shares)
Q2 2021
Avg closing price
$38.89
Price range
$35.91
-
$40.68
News about Pfizer Inc. and Ken Griffin
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
Hedge funds managed by Israel Englander and Ken Griffin both scooped up shares in a troubled pharmaceutical stock last quarter.
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
Ken Griffin's Citadel continues to add to its position in Pfizer.